Theorem Clinical Research Inc entered the industry of Research and Development Laboratories in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 541712, which describes it as a Research and Development Laboratories. For further clarification, the SIC classifies this business under the code 8731 and described it as a Research and Development Laboratories. The business provides service to the B2B market.
To acquire more information, please contact by calling (434) 791-3675 during business hours. You can also write to the business’ Branch at 4124 East 32nd Avenue, Spokane, Washington WA 99223. You can also visit the company’s website at theoremclinical.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Theorem Clinical Research Inc |
Place of Business: | 4124 East 32nd Avenue, Spokane, WA 99223 |
Contact Number: | (434) 791-3675 |
Website: | theoremclinical.com |
Type of Service: | Research and Development Laboratories |
SIC Number: | 8731 |
NAICS Number: | 541712 |
Locality: | Branch |
Market Type: | B2B (Business to Business) |
Income/Year: | Unknown |
Laborers: | 1 to 4 |
Share This Company: |
Theorem Clinical Research Inc is a company operating from Spokane, Washington providing professional Research and Development Laboratories and relevant B2B variables. It was founded in 0 and registered with the SIC code 8731 as Research and Development Laboratories, and with the NAICS code 541712 as Research and Development Laboratories.
With a current employee count of 1 to 4, Theorem Clinical Research Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative at (434) 791-3675 for related queries, or to locate its Branch using the coordinates .
The Branch can also be found at the street address 4124 East 32nd Avenue in Spokane, Washington 99223 and can be engaged online through the company website at theoremclinical.com, the company Twitter , and Facebook page .